Viewing Study NCT06028594


Ignite Creation Date: 2025-12-25 @ 1:40 AM
Ignite Modification Date: 2025-12-25 @ 11:56 PM
Study NCT ID: NCT06028594
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2025-10-17
First Post: 2023-08-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Compassionate Use of Pozelimab and Cemdisiran Combination Therapy in Patients With Paroxysmal Nocturnal Hemoglobinuria
Sponsor: Regeneron Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module